Abbott Laboratories
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2006 | — | — | $521.2M |
| FY2007 | $21.94B | $39.71B | $2.46B |
| FY2008 | $24.94B | $42.42B | $4.11B |
| FY2009 | $29.44B | $52.58B | $8.81B |
| FY2010 | $37.90B | $60.57B | $3.65B |
| FY2011 | $35.84B | $60.28B | $6.81B |
| FY2012 | $40.51B | $67.24B | $10.80B |
| FY2013 | $17.77B | $42.94B | $3.48B |
| FY2014 | $19.68B | $41.21B | $4.06B |
| FY2015 | $20.04B | $41.25B | $5.00B |
| FY2016 | $32.13B | $52.67B | $18.62B |
| FY2017 | $45.35B | $76.25B | $9.41B |
| FY2018 | $36.65B | $67.17B | $3.84B |
| FY2019 | $36.80B | $67.89B | $3.86B |
| FY2020 | $39.76B | $72.55B | $6.84B |
| FY2021 | $39.39B | $75.20B | $9.80B |
| FY2022 | $37.75B | $74.44B | $9.88B |
| FY2023 | $34.61B | $73.21B | $6.90B |
| FY2024 | $33.75B | $81.41B | $7.62B |
| FY2025 | $34.58B | $86.71B | $8.52B |